Exscientia analyst ratings
Exscientia analyst ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
06/13/2022 | 55.76% | Morgan Stanley | $21 → $20 | Maintains | Equal-Weight |
05/24/2022 | 55.76% | Goldman Sachs | $23 → $20 | Maintains | Buy |
04/11/2022 | 63.55% | Morgan Stanley | $20 → $21 | Maintains | Equal-Weight |
10/26/2021 | 110.28% | B of A Securities | → $27 | Initiates Coverage On | → Buy |
10/26/2021 | 94.7% | Morgan Stanley | → $25 | Initiates Coverage On | → Equal-Weight |
10/26/2021 | 133.64% | Goldman Sachs | → $30 | Initiates Coverage On | → Buy |
Exscientia Questions & Answers
The latest price target for Exscientia (NASDAQ: EXAI) was reported by Morgan Stanley on June 13, 2022. The analyst firm set a price target for $20.00 expecting EXAI to rise to within 12 months (a possible 55.76% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Exscientia (NASDAQ: EXAI) was provided by Morgan Stanley, and Exscientia maintained their equal-weight rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exscientia, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exscientia was filed on June 13, 2022 so you should expect the next rating to be made available sometime around June 13, 2023.
While ratings are subjective and will change, the latest Exscientia (EXAI) rating was a maintained with a price target of $21.00 to $20.00. The current price Exscientia (EXAI) is trading at is $12.84, which is out of the analyst's predicted range.
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
06/13/2022 | 55.76% | Morgan Stanley | $21 → $20 | Maintains | Equal-Weight |
05/24/2022 | 55.76% | Goldman Sachs | $23 → $20 | Maintains | Buy |
04/11/2022 | 63.55% | Morgan Stanley | $20 → $21 | Maintains | Equal-Weight |
10/26/2021 | 110.28% | B of A Securities | → $27 | Initiates Coverage On | → Buy |
10/26/2021 | 94.7% | Morgan Stanley | → $25 | Initiates Coverage On | → Equal-Weight |
10/26/2021 | 133.64% | Goldman Sachs | → $30 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
06/13/2022 | 55.76% | 摩根士丹利 | $21 → $20 | 維護 | 等重 |
05/24/2022 | 55.76% | 高盛 | $23 → $20 | 維護 | 買 |
04/11/2022 | 63.55% | 摩根士丹利 | $20 → $21 | 維護 | 等重 |
10/26/2021 | 110.28% | B of A證券 | → $27 | 開始承保 | →購買 |
10/26/2021 | 94.7% | 摩根士丹利 | → $25 | 開始承保 | →等重 |
10/26/2021 | 133.64% | 高盛 | → $30 | 開始承保 | →購買 |
Exscientia Questions & Answers
《科學問答》
The latest price target for Exscientia (NASDAQ: EXAI) was reported by Morgan Stanley on June 13, 2022. The analyst firm set a price target for $20.00 expecting EXAI to rise to within 12 months (a possible 55.76% upside). 6 analyst firms have reported ratings in the last year.
納斯達克(Sequoia Capital:EXAI)的最新目標價是由摩根士丹利於2022年6月13日報道的。這家分析公司將目標價定為20.00美元,預計EXAI將在12個月內上漲至55.76%。6家分析公司在過去一年公佈了評級。
The latest analyst rating for Exscientia (NASDAQ: EXAI) was provided by Morgan Stanley, and Exscientia maintained their equal-weight rating.
納斯達克(Sequoia Capital:EXAI)的最新分析師評級由摩根士丹利提供,ExScience a維持其同等權重評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exscientia, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exscientia was filed on June 13, 2022 so you should expect the next rating to be made available sometime around June 13, 2023.
分析師在進行了廣泛的研究後得出了股票評級,其中包括查閲公共財務報表,與ExScience a的高管和客户交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。ExScience a的上一次評級是在2022年6月13日提交的,所以你應該預計下一次評級將在2023年6月13日左右的某個時候公佈。
While ratings are subjective and will change, the latest Exscientia (EXAI) rating was a maintained with a price target of $21.00 to $20.00. The current price Exscientia (EXAI) is trading at is $12.84, which is out of the analyst's predicted range.
雖然評級是主觀的,並將發生變化,但最新的ExScience a(EXAI)評級維持不變,目標價在21.00美元至20.00美元之間。目前ExScience a(EXAI)的交易價格為12.84美元,超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧